Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma

Fig. 4

Kaplan–Meier curves of progression-free survival in total and R-CHOP-treated diffuse large B cell lymphoma patients. Survival analysis for progression-free survival (PFS) according to PD-L1t in total cohort (n = 107) (a) and R-CHOP cohort (n = 93) (b), and according to PD-L1i in total cohort (c) and R-CHOP cohort (d). Survival analysis for PFS according to pSTAT3 (40% cutoff) in total cohort (e) and R-CHOP cohort (f). *T: tumor cell; I: immune cell

Back to article page